contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


vivesto-holds-a-live-streamed-business-update-today-november-24

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Vivesto is a pharmaceutical company focused on developing innovative treatments for serious oncology diseases. The company is researching new therapies that can improve patient outcomes and quality of life. The company operates globally with a primary presence in Europe and North America. Vivesto was founded in 1988 and is headquartered in Uppsala, Sweden.

Vivesto

Solna, Sweden, November 24, 2025 – Vivesto AB, an oncology-focused development company, holds a live-streamed business update today, November 24 at 15:00 CET, focusing on the recent pipeline...

<div class="mfn-preamble">Solna, Sweden, November 24, 2025 – Vivesto AB, an oncology-focused development company, holds a live-streamed business update today, November 24 at 15:00 CET, focusing on the recent pipeline advancements, including the positive interim efficacy results observed in the open label, clinical pilot study with Paccal Vet in dogs with splenic hemangiosarcoma following splenectomy, as well as the positive anti-cancer effects of Cantrixil shown in several preclinical hematological cancer models.</div><div class="mfn-body">The business update will focus on the Paccal Vet and Cantrixil programs, including details about the recent results, the development plans going forward, medical needs and commercial potential.Speakers includes:External speakers<ul><li>Henrik Rönnberg, Professor in veterinary pharmacology (DiplECVIM-CA, oncology)</li><li>Jim Perry, Veterinary oncologist and surgeon, DVM, PhD, CEO CASTR Alliance</li><li>Bjørn Tore Gjersten, Professor of hematology, University of Bergen</li></ul>Vivesto speakers<ul><li>Peter Zonabend, Chairman of the Board</li><li>Erik Kinnman, CEO</li><li>Teresa Fernandez Zafra, Chief Scientific Officer</li><li>Johanna Röstin, Chief Regulatory Officer</li><li>Nina Herne, Consultant, PhD, MBA, Senior Consultant</li></ul>Agenda: 15.00 – 15.10 Introduction 15.10 – 15.55 Paccal Vet Development vet industry Key achievements dog and cat studies Medical need and clinical studies Development plan 15.55 – 16.15 Cantrixil Medical need AML Pre-clinical data Development plans Vet opportunity 16.15 – 16.20 Commercial potential 16.20 – 16.30 Summary 16.30 Q&amp;AThe presentations will be followed by a Q&amp;A session where questions can be submitted in advance via&nbsp;<a rel="noopener" href="mailto:info@vivesto.com">info@vivesto.com</a>The presentations will be held in English and can be followed via&nbsp;<a rel="noopener" href="https://www.youtube.com/live/mMvLyL0w9WY">https://www.youtube.com/live/mMvLyL0w9WY</a> and will also be available afterwards on Vivesto's website. No registration is required.</div><div class="mfn-footer mfn-contacts mfn-be3c1519868c">For More Information:<hr>Erik Kinnman, Chief Executive Officer Phone: +46 018-50 54 40 E-mail:&nbsp;IR@vivesto.com</div><div class="mfn-footer mfn-about mfn-6116d727a4e1">About Vivesto AB<hr>Vivesto is a Swedish development company that aims to offer new treatment options for hard-to-treat cancers where there are major medical needs and significant market potential. The project portfolio consists of Cantrixil, which is being developed for blood cancer, and the veterinary oncology program Paccal Vet (paclitaxel micellar), which is being evaluated in a pilot clinical trial in dogs with splenic hemangiosarcoma following splenectomy and in a dose-finding study in cats with solid tumors.Vivesto’s shares are traded on Nasdaq Stockholm (ticker: VIVE). Visit www.vivesto.com for more information about Vivesto.</div><div class="mfn-footer mfn-attachment mfn-attachment-general">Attachments<hr><a rel="noopener" href="https://storage.mfn.se/ca7a12b9-5be5-47d1-92cf-d0cf36b197c4/vivesto-holds-a-live-streamed-business-update-today-november-24.pdf" class="mfn-generated mfn-primary">Vivesto holds a live-streamed business update today November 24</a></div>